TrialCancer2014

Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.

Kaoru Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.